Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Cathrine L. Denton
Observed names:
C. L. Denton,
Cathrine Denton,
Denton, C. L.,
Denton, Cathrine L.
Observed institutions:
University of North Carolina at Chapel Hill,
Duke University,
GlaxoSmithKline (United States),
Duke Medical Center,
University of Colorado Denver,
Colorado State University
show all 6
OpenAlex ID:
A5043461982
Comparative analysis of MAPK and PI3K/AKT pathway activation and inhibition in human and canine melanoma
2013
·
J. S. Fowles
, C. L. Denton
, et al.
·
Veterinary and Comparative Oncology
·
78
Pharmacokinetics and pharmacodynamics of AZD6244 (ARRY-142886) in tumor-bearing nude mice
2010
·
Cathrine L. Denton
, Daniel L. Gustafson
·
Cancer Chemotherapy and Pharmacology
·
49
Concomitant Oral and Intravenous Pharmacokinetics of Dabrafenib, a BRAF Inhibitor, in Patients with BRAF V600 Mutation‐Positive Solid Tumors
2013
·
Cathrine L. Denton
, Elisabeth Minthorn
, et al.
·
The Journal of Clinical Pharmacology
·
39
Pharmacology of DB844, an Orally Active aza Analogue of Pafuramidine, in a Monkey Model of Second Stage Human African Trypanosomiasis
2012
·
John K. Thuita
, Michael Z. Wang
, et al.
·
PLoS neglected tropical diseases
·
39
PDF
Analysis of HIV-1 subtype B third variable region peptide motifs for induction of neutralizing antibodies against HIV-1 primary isolates
2005
·
Barton F. Haynes
, Benjiang Ma
, et al.
·
Virology
·
37
PDF
Abstract 3773: Absolute bioavailability of BRAF inhibitor GSK2118436: Use of a microtracer study in patients with cancer
2012
·
Cathrine L. Denton
, Stanley W. Carson
, et al.
·
Cancer Research
·
1
Pharmacology of DB844, an Orally Active aza Analogue of Pafuramidine, in a Monkey Model of Second Stage Human African Trypanosomiasis
2020
·
Denton, Cathrine L.
, Tidwell, Richard R.
, et al.
·
Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
Rates of proliferation of human melanoma may predict sensitivity to small molecule MEK inhibition
2007
·
Cathrine L. Denton
, Daniel L. Gustafson
·
Molecular Cancer Therapeutics
Show more works
View as search
Works count:
10
Citation count:
243
H-index:
5
I10-index:
5
Year
Topic
Type
